DR. ANDREW GODWIN RECEIVES NATIONAL INSTITUTES OF HEALTH GRANT
“A team led by Andrew Godwin, PhD, deputy director of The University of Kansas Cancer Center and director of molecular oncology in the department of Pathology and Laboratory Medicine, has been awarded a five-year, $11.4 million National Institutes of Health phase I Centers for Biomedical Research Excellence (COBRE) grant to establish the Kansas Institute for Precision Medicine at the University of Kansas Medical Center.”
CLICK HERE to read more.
Tina’s Wish Researcher Dr. Andrew Godwin is the Chancellors Distinguished Chair in Biomedical Sciences endowed Professor and the Director of Molecular Oncology at The University of Kansas Medical Center. To learn more about Dr. Godwin’s research with Tina’s Wish, CLICK HERE.